Cargando…

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?

BACKGROUND AND PURPOSE: Whether the neuromelanin‐positive substantia nigra pars compacta area (NM‐SNc) on neuromelanin magnetic resonance imaging (NM‐MRI) and the specific binding ratio (SBR) on (123)I‐N‐v‐fluoropropyl‐2b‐carbomethoxy3b‐(4‐iodophenyl)nortropane single photon emission computed tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okuzumi, A., Hatano, T., Kamagata, K., Hori, M., Mori, A., Oji, Y., Taniguchi, D., Daida, K., Shimo, Y., Yanagisawa, N., Nojiri, S., Aoki, S., Hattori, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851628/ https://www.ncbi.nlm.nih.gov/pubmed/31136060 http://dx.doi.org/10.1111/ene.14009

Ejemplares similares

Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI
por: Le Berre, Alice, et al.
Publicado: (2019)

DaT Scan “Abnormality” in Hyperglycemic-Hemichorea
por: Doher, Nicholas, et al.
Publicado: (2019)

Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study
por: Menéndez-González, Manuel, et al.
Publicado: (2014)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments
por: Rahmim, Arman, et al.
Publicado: (2016)

Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022)

Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study
por: Tsang, Kaki, et al.
Publicado: (2023)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)

The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease
por: Lorio, Sara, et al.
Publicado: (2019)

Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes
por: Shigekiyo, Taro, et al.
Publicado: (2020)

Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images
por: Rahmim, Arman, et al.
Publicado: (2017)

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression
por: Jackson, Holly, et al.
Publicado: (2021)

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2020)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI study
por: Choi, Sunah, et al.
Publicado: (2023)

Tracemetals, neuromelanin and neurodegeneration: An interesting area for research
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2007)

Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015)

Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin
por: Nakamura, Ken, et al.
Publicado: (2014)

White matter microstructures in Parkinson's disease with and without impulse control behaviors
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2022)

Unraveling the contributions to the neuromelanin-MRI contrast
por: Priovoulos, Nikos, et al.
Publicado: (2020)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
por: Liu, Qiang, et al.
Publicado: (2023)

The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2021)

Prediction of Cognitive Decline in Parkinson’s Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems
por: Hosseinzadeh, Mahdi, et al.
Publicado: (2023)

White matter and nigral alterations in multiple system atrophy-parkinsonian type
por: Ogawa, Takashi, et al.
Publicado: (2021)

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
por: Saiki, Shinji, et al.
Publicado: (2017)

Test of DAT-DISP
Publicado: (1980)

Multi-Atlas MRI-Based Striatum Segmentation for (123)I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson's Disease/Syndrome
por: Sohara, Koji, et al.
Publicado: (2021)

Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects
por: Pak, Kyoungjune, et al.
Publicado: (2023)

Experimental evaluation of absolute quantification in (99m)Tc‐TRODAT‐1 SPECT/CT brain dopamine transporter (DAT) studies
por: Zainudin, Norasma Amira, et al.
Publicado: (2022)

Neuromelanin is an immune stimulator for dendritic cells in vitro
por: Oberländer, Uwe, et al.
Publicado: (2011)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
por: Nagatsu, Toshiharu, et al.
Publicado: (2022)

The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies
por: Wulf, Maximilian, et al.
Publicado: (2022)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Assessment of different regions of interest-based methods for [99mTc]Tc DAT-SPECT quantification using an anthropomorphic striatal phantom
por: Alexandre-Santos, Leonardo, et al.
Publicado: (2022)

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
por: Ueno, Shin‐Ichi, et al.
Publicado: (2020)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Locus coeruleus neuromelanin accumulation and dissipation across the lifespan
por: Riley, Elizabeth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ie5iooq1s55nr6o06fj7prv82